6&7 December Hotel Realm - aamri.org.au · PDF fileMiss Samantha Ludolf Deputy Director, Strategy & Operations Walter and Eliza Hall Institute of Medical Research

2017 ANNUAL CONVENTION6&7 December Hotel Realm18 National Circuit, Barton, ACT

2

AAMRI MEMBERS

EVENT CONTACTS Peter Thomas, 0411 600 992, [email protected]

Kathryn Naumenko, 0402 117 529, [email protected]

Cath Latham, 0413 865 459, [email protected]

3

CONVENTION PROGRAM

WED 6 DEC

9.00am REGISTRATION OPENS 9.30am-12.30pm MRI BUSINESS MANAGERS’ MEETING

National Ballroom 2, Hotel Realm Canberra Pages 7-14

12.30pm-1.30pm LUNCH

National Ballroom 1, Hotel Realm Canberra

1.30pm-5.00pm AAMRI STRATEGY MEETING


5.30pm-6.30pm MRI BOARD MEMBER PRE-DINNER DRINKS

High Courtyard South, Hotel Realm Canberra

6.30pm COURTESY BUSES FROM HOTEL REALM TO

PARLIAMENT HOUSE Depart from the rear of Hotel Realm, in Burbury Close

7.00pm 2017 AAMRI ANNUAL DINNER

Great Hall, Parliament House Guest speaker: The Hon Greg Hunt MP, Minister for Health, Minister for Sport

10.15PM Courtesy bus from Parliament House to Hotel Realm

Canberra

THURS 7 DEC

7.30am-8.30am AAMRI PRESIDENT’S BREAKFAST National Ballroom 2, Hotel Realm Canberra Guest speaker: The Hon Bill Shorten MP, Leader of the Opposition

8.45am-11.00am AAMRI AGM (REGISTRATION FROM 8.30AM)


PARTICIPANTS

4

Mr Peter Allen Board Chair Wesley Medical Research

Ms Gina Anderson Board Member The George Institute for Global Health

Mr Richard Balderstone Board Olivia Newton-John Cancer Research Institute

Dr Johanna Barclay Research Development Manager Mater Medical Research Institute

Mr Mark Bizeray CFO Children's Cancer Institute

Mr David Blair COO Menzies School of Health Research

Ms Hilary Bolton Executive General Manager, Operations

Baker Heart & Diabetes Institute

Mr Ian Briggs Chief Technology Officer Baker Institute, Burnet Institute, CERA

Mr Matthew Browne CFO & Company Secretary Melanoma Institute Australia

Ms Lee Bruce Director Corporate Services Translational Research Institute

Ms Anna Burke Board Director Institute for Breathing and Sleep

Ms Lee Byrne Projects and Communications Specialist

Walter and Eliza Hall Institute of Medical Research

Prof Jonathan Carapetis Director Telethon Kids Institute

Prof John Carroll Director/Dean Monash Biomedicine Discovery Institute

Mr Joseph Carrozzi Partner PwC

Prof Helen Christensen Chief Scientist and Director Black Dog Institute

A/Prof Stella Clark Board Member Bionics Institute

Ms Nicole Cockayne Director Discovery and Innovation Black Dog Institute

Mr Matt Cousins Manager John Curtin School of Medical Research

Prof Brendan Crabb AC CEO Burnet Institute

Mr Michael Creevey Acting CEO - endpointIQ QIMR Berghofer Medical Research Institute

Mr Malcolm Crompton AM Chair PRAXIS Australia

Prof Tony Cunningham AO President AAMRI

Prof Peter Currie Director Australian Regenerative Medicine Institute

Mr John Dakin COO Westmead Institute for Medical Research

Ms Joanne Darmanin Associate Director - IT Orygen, The National Centre of Excellence in Youth Mental Health

Mr Russell D'Costa Operations Manager Centre for Cancer Biology

Dr Henry De Aizpurua Deputy Director The Florey Institute of Neuroscience and Mental Health

Dr Nicole den Elzen Executive General Manager, Research Management & Strategy

Baker Heart & Diabetes Institute

Mr Andrew Dermott Finance Manager Neuroscience Research Australia

Prof Geoffrey Donnan AO Director The Florey Institute of Neuroscience and Mental Health

Mr Brendon Douglas Director of Research Menzies School of Health Research

A/Prof Briony Dow Director National Ageing Research Institute

Dr James Dromey COO Murdoch Children's Research Institute

Dr. Bob Edgar Board Chair Hudson Institute of Medical Research

Mrs Joanne Elliot COO Woolcock Institute of Medical Research

Mr Gerald Ewing CEO Regis Mutual Management

Dr Alan Finkel AO Australian Chief Scientist Office of the Chief Scientist

Prof Simon Foote Director John Curtin School of Medical Research

Mr Peter Forbes Chair Lions Eye Institute

Mrs Carolyn Forster OAM Board Vice President Children's Medical Research Institute

Prof Ian Frazer AC President Australian Academy of Health and Medical Sciences

Prof Frank Gannon Director and CEO QIMR Berghofer Medical Research Institute

Mrs Melanie Gentgall CEO PRAXIS Australia

5

Dr Parisa Glass Director of Operations The George Institute for Global Health

Mr Marcus Goddard Business Manager Robinson Research Institute

Mr Peter Gover COO Bionics Institute

Prof Michelle Haber AM Executive Director Children's Cancer Institute

Mr Darryl Harkness CEO Ingham Institute for Applied Medical Research

Prof Elizabeth Hartland Director and CEO Hudson Institute of Medical Research

Dr Andy Hastings Manager, VicAAMRI AAMRI

Prof Doug Hilton AO Director Walter and Eliza Hall Institute of Medical Research

Dr Stephen Hollings CEO Heart Research Institute

Mr Larry Iffla Chair Harry Perkins Institute of Medical Research

Ms Janina Jancu COO Victor Chang Cardiac Research Institute

Dr Anne Johnston Head, Research Strategy St Vincent's Institute of Medical Research

Dr Kate Johnston COO Neuroscience Research Australia

Mr Peter Joseph Chair Black Dog Institute

Prof Thomas Kay Director St Vincent's Institute of Medical Research

Prof Anne Kelso AO Chief Executive Officer National Health and Medical Research Council

Dr Maree Knight Deputy Director Operations Mater Medical Research Institute

Prof Sharad Kumar Co-Director Centre for Cancer Biology

Dr Cath Latham Policy & Project Officer AAMRI

Mrs Lien Le Deputy Director RDS/Nectar/ANDS

Prof Peter Leedman Director Harry Perkins Institute of Medical Research

Mrs Kate LeMay Senior Research Data Specialist Australian National Data Service

Mr David Lloyd Deputy Director/COO Baker Heart & Diabetes Institute

Mr Kyle Loades Chair Hunter Medical Research Institute

Prof Angel Lopez AO Co-Director Centre for Cancer Biology

Miss Samantha Ludolf Deputy Director, Strategy & Operations

Walter and Eliza Hall Institute of Medical Research

Mrs Jacinta Mackey Chief Operating & Financial Officer Centre for Eye Research Australia

Prof David Mackey Managing Director Lions Eye Institute

Ms Sue MacLeman CEO & Managing Director MTPConnect

Prof Frank Martin AM Chair Children’s Medical Research Institute

Dr Alfredo Martinez-Coll General Manager, Stakeholder Engagement

MTPConnect

Mr Rory McQuillan COO Monash Biomedicine Discovery Institute

Mr Rob Merriel CFO Hudson Institute of Medical Research

Mr Andrew Mir CFO Brien Holden Vision Institute

Mr Ralph Mitchell COO Children's Medical Research Institute

Prof Maxine Morand Chair, Board of Directors Peter MacCallum Cancer Centre

Mr Ian Mundy Member Services Director Unimutual

Ms Kathryn Naumenko Events & Administration Assistant AAMRI

Prof Kathryn North AM Director Murdoch Children's Research Institute

Ms Debra O'Connor Deputy Director National Ageing Research Institute

A/Prof Peter O'Loughlin Acting Head Hanson Institute

Dr Nick Pearce COO Centenary Institute

Prof Vlado Perkovic Executive Director The George Institute for Global Health

Prof Karlheinz Peter Deputy Director Baker Heart & Diabetes Institute

Prof Mark Radford CEO Queensland Eye Institute

PARTICIPANTS

6

Prof Roger Reddel Director Children's Medical Research Institute

Mr Tim Regan COO The George Institute for Global Health

Mr Jon Rhoades IT Manager St Vincent's Institute of Medical Research

Prof Sarah Robertson Director Robinson Research Institute

Ms Kelly Rodger VIP AAMRI

Mr Tobias Schoep Senior Research Development Officer

Telethon Kids Institute

Prof Peter Schofield Executive Director & CEO Neuroscience Research Australia

Mr Peter Scott Deputy Chair Gresham

Ms Brenda Shanahan Board Chair St Vincent's Institute of Medical Research

Mr Mark Sheridan Chair Queensland Eye Institute

Prof Carolyn Sue Director Kolling Institute

Mrs Julie Taranto Research Operations Manager/RAO

ANZAC Research Institute

Mr Mark Tennent COO Burnet Institute

Mr Chris Thomas Chair Walter and Eliza Hall Institute of Medical Research

Dr Peter Thomas Director of Policy and Operations AAMRI

Dr Anne Thorburn Head of Operations, Administration

St Vincent's Institute of Medical Research

Prof Joseph A. Trapani Executive Director Cancer Research

Peter MacCallum Cancer Centre

Ms Kim Tsai COO / CFO Olivia Newton-John Cancer Research Institute

Prof Mathew Vadas AO Director Centenary Institute

Prof Alison Venn Director Menzies Institute for Medical Research

Mr Paul Watt Director of Research Services and Innovation

Telethon Kids Institute

Mr Rod Wealands COO Hudson Institute of Medical Research

Dr Peter Wejbora Head of Research Development & Partnerships

Children's Cancer Institute

Prof Steve Wesselingh Executive Director South Australian Health and Medical Research Institute

Mr Chris Whitelock COO Lions Eye Institute

Prof Stephen Wood Associate Director, Research Orygen, The National Centre of Excellence in Youth Mental Health

Mr Nicholas Wood Director of Corporate Services Telethon Kids Institute

7

MRI BUSINESS MANAGERS’ MEETING WEDNESDAY 6 DECEMBER, 9.00AM – 12.30PM National Ballroom 2, Hotel Realm Canberra Chair: Dr Cath Latham, Policy & Project Officer, AAMRI 9.00am REGISTRATION OPENS 9.30am WELCOME

Session Chair: Dr Cath Latham, AAMRI 9.35am-10.25am OPPORTUNITIES FOR MRIS: NATIONAL FACILITIES FOR RESEARCH

DATA MANAGEMENT 9.35am

MRIs and Data Sharing Ms Kate LeMay, Senior Research Data Specialist, Australian National Data Service (ANDS)

9.50am Opportunities for MRIs at RDS and Nectar

Dr Lien Le, Deputy Director, Research Data Services (RDS) 10.05am Connecting Colorectal cancer data and making it FAIR

Professor Steve Wesselingh, Executive Director, South Australian Health and Medical Research Institute (SAHMRI)

10.15am Q&A panel: Research Data Services and Collaboration

with Kate LeMay, Lien Le and Steve Wesselingh 10.25am THE POWER OF PATTERNS IN BIG DATA – HOW AND WHEN CAN

DATA BE REPURPOSED? Mr Malcolm Crompton AM, Chair, PRAXIS Australia Ltd

10.50am MORNING TEA - SPONSORED BY PRAXIS AUSTRALIA

To be held in National Ballroom 1 11.20am DATA GROWTH IN MEDICAL RESEARCH – CHALLENGES AND

OPPORTUNITIES Mr Ian Briggs, Chief Technology Officer for the Baker Institute, Burnet Institute & Centre for Eye Research (CERA)

11.45am BESPOKE SOFTWARE SYSTEMS FOR THE ENTIRE RESEARCH

LIFECYCLE Mr Michael Creevey, Chief Executive, Endpoint IQ

12.05pm RISKY BUSINESS - INSURING THE UNINSURABLE THROUGH

COLLABORATION Mr Ralph Mitchell, Chief Operating Officer, Children's Medical Research Institute Mr Gerald Ewing, Chief Executive, Unimutual Mr Ian Mundy, Member Services Director, Unimutual

MRI BUSINESS MANAGERS’ MEETING

8

KATE LEMAY Senior Research Data Specialist Australian National Data Service (ANDS)

OPPORTUNITIES FOR MRIS: NATIONAL FACILITIES FOR RESEARCH DATA MANAGEMENT

MRIs and Data Sharing

The Australian National Data Service (ANDS), National eResearch Collaboration Tools and Resources project (Nectar), and Research Data Services (RDS) are all federally funded projects through the National Collaborative Research Infrastructure Strategy (NCRIS) funding scheme. ANDS, Nectar and RDS provide data infrastructure and services to research institutions across Australia. in 2018 the three projects are merging to provide an aligned data service to support Australia's research sector. Lien Le and Kate LeMay will outline the aims of each of the projects and how these impact upon Medical Research Institutes.

ANDS works to make Australia’s research data assets more valuable for researchers, research institutions and the nation. Research is producing larger and more complex data than ever before. It is imperative that these data outputs are effectively managed and shared. Better data – better described, more connected, more integrated and organised, more accessible, more easily used for new purposes – allows new questions to be answered, larger issues to be investigated, and data landscapes to be explored. Kate LeMay will outline the principles of data management and sharing, and what is happening in the international medical research community to facilitate these. She will discuss what Australian researchers can do to keep up with international movements.

ABOUT KATE

Kate LeMay began her career as a Pharmacist, working in both community and hospital settings. Kate moved on to the Woolcock Institute of Medical Research, where she worked on community pharmacy based programs to assist patients with chronic disease management. Kate is now in Canberra at the Australian National Data Service (ANDS) as a Senior Research Data Specialist, focusing on health and medical data.


9

DR LIEN LE Deputy Director Research Data Services (RDS)


Opportunities for MRIs at RDS and Nectar

Lien will outline the work of Nectar and RDS, specifically touching on two projects, med.data.edu.au and BPA/omics, which are of particular relevance to the medical research sector. Nectar provides an online infrastructure that supports researchers to connect with colleagues in Australia and around the world, collaborate and share ideas and research outcomes, and ultimately contribute to our collective knowledge. RDS is a continuation of the Research Data Storage Infrastructure (RDSI), which established a number of components including a high-capacity storage nodes, a dedicated high-bandwidth, low-latency inter-connection network to support data transfer and replication. RDSI brought this together with the implementation of common access infrastructure that provides a uniform user access experience, and appropriate specialised access infrastructure, including the hosting of specialist access tools related to national collections. RDS leverages this infrastructure to provide efficient and user friendly services for the research community.

About Lien

Lien is the Deputy Director with the Research Data Services (RDS) Project at the University of Queensland, an initiative funded by the Australian Government to support research data infrastructure and services. Lien is tasked with providing technical and strategic direction to the project managers overseeing the RDS domain projects. Her early priorities have included liaising with all the big partners and determining what their needs are throughout their projects. Lien was previously the Senior Bioinformatics Team Leader at the Research Computing Centre, University of Queensland. She formed part of the Queensland EMBL Bioinformatics Resource node in conjunction with the hub at the University of Melbourne to gather bioinformatics expertise. She instigated and led the successful setup of an Australian based data repository. Lien's previous appointments have been with the Australian Genome Research Facility as their Bioinformatics Supervisor and with the Queensland Institute of Medical Research as their Bioinformatics Specialist.


10

PROFESSOR STEVE WESSELINGH Executive Director South Australian Health and Medical Research Institute (SAHMRI)


Connecting Colorectal cancer data and making it FAIR

There is a pressing need to connect registry data and administrative health data and test the quality and utility of these linked data such that results will have credibility both for research and for health-service performance assessment. Through this project SAHMRI has linked Medicare Benefits Schedule (MBS)/Pharmaceutical Benefits Scheme (PBS) and other Commonwealth data with Cancer Registry data, using the Australian Institute of Health and Welfare’s (AIHW) data linkage unit. These data are now being used to identify unexplained variations in health care and to set program directions for research translation initiatives to strengthen health-system performance, clinical practice and public policy in SA. This presentation will describe the lessons learned in this project including what it means to make data more FAIR (Findable, Accessible, Interoperable and Reusable) taking into account the sensitive nature of this data.

About Steve

Professor Wesselingh is an Infectious Diseases Physician and researcher in neurovirology, HIV and vaccine development who has consistently worked towards the integration of high quality medical research with health-care delivery, leading to improved health outcomes for Australia and the poorly resourced countries of the region. In October 2011 Professor Steve Wesselingh took up the position as the inaugural Executive Director of the South Australian Health and Medical Research Institute (SAHMRI) and is the Infection and Immunity Theme Leader for the institute. Before moving to Adelaide, Steve held positions in Melbourne as the Director of the Burnet Institute, an independent medical research institute specialising in infectious diseases, immunology and public health, and Dean of the Faculty of Medicine, Nursing and Health Sciences at Monash University (2007-2011). Steve completed his undergraduate and doctoral training at Flinders University/Flinders Medical Centre in South Australia and his post-doctoral training at Johns Hopkins in the United States.


11

MR MALCOLM CROMPTON AM Chair PRAXIS Australia Ltd

THE POWER OF PATTERNS IN BIG DATA – HOW AND WHEN CAN DATA BE REPURPOSED?

Big Data is one of the themes of our time, but when can personal information be used in a Big Data context, and how? This session will review relevant requirements of the Privacy Act then examine in recent guidance from the Office of the Australian Information Commissioner in more detail.

ABOUT MALCOLM

Malcolm Crompton is founder and Managing Director of Information Integrity Solutions Pty Ltd (IIS), a global consultancy specialising in data protection and privacy strategies. His global reputation is built on forward thinking about the handling and governance of personal information.

As Australia’s Privacy Commissioner from 1999 to 2004, Malcolm led the implementation of the nation’s first broad based private sector privacy law. He has been a member of advisory bodies around the world, including the European Union, OECD and APEC as well as large global companies such as Microsoft and IBM. He is also Chair and a founding Director of Praxis Australia Limited and has been a director of Bellberry Limited since 2006, two not for profit companies providing ethics committee services and training for research on humans.

Malcolm has degrees in Chemistry and Economics, is a Certified Information Privacy Professional and is a Fellow of the Australian Institute of Company Directors. He was made a Member of the Order of Australia in the 2016 Queen’s Birthday Honours for significant service to public administration, particularly to data protection, privacy, and identity management, and to the community.


12

MR IAN BRIGGS Chief Technology Officer Baker Institute, Burnet Institute & Centre for Eye Research (CERA)

DATA GROWTH IN MEDICAL RESEARCH – CHALLENGES AND OPPORTUNITIES

At the core of all medical research is data. The collection, analysis, storage, retention and retrieval of data are the foundation of the scientific method. Data represents a significant monetary and scientific investment, not only in tangible funding, but in the intangible hard work of scientists.

Retention of data is crucial for replication and validation of scientific analysis, and provision of online access to datasets is increasingly required by journals and the peer review process. There is a requirement for all scientific data, particularly sensitive patient information, to be protected and securely held.

With local and worldwide trends demonstrating enormous growth rates in medical research related data, an opportunity exists to establish an industry wide secondary off-site storage model. This private medical research cloud based storage system will allow institutes to connect to it via a high speed link, enabling them to easily back-up and archive their data. The system will be based on industry best practice security protocols and will lead to the creation of a central repository for Australia’s medical research data and intellectual property. It will also drive down the costs of data storage institutes currently face.

ABOUT IAN

Ian is the Chief Technology Officer for The Baker Institute, The Burnet Institute and the Centre for Eye Research Australia, a unique collaboration he has led since 2016. More recently the collaboration has expanded with the formation of a single IT team shared by all three medical research institutes. Prior to his current position, he was the head of the IT team at the Baker Institute for the past 13 years, following on from 7 years running the IT services for a large metropolitan hospital. Ian has a Bachelor of Economics and Accounting from Monash University.

Ian has strong interests in efficiency, collaboration and mentorship as a way of maximizing the contribution of Information Technology to the business of Medical Research. Collaboration amongst teams and institutes is an effective way to drive overall costs down, and this was highlighted with the creation of an innovative, shared storage approach for Baker, Burner and CERA which allows the institutes to generate large savings relating to the cost of data storage. With data storage requirements growing at an astounding rate across the medical research sector, more recently Ian has turned his attention to a possible industry wide approach to solve this problem and reduce the overall cost related to it.


13

MR MICHAEL CREEVEY Chief Executive Endpoint IQ

Bespoke software systems for the entire research lifecycle

Research management software that can deliver the specific functionality required for medical research institutes (MRIs) at the rates we can justify is almost non-existent. Often software vendors need to 'bend' systems designed for other industries to meet just some of our needs. This results in lengthy implementation periods, limited flexibility when research policies change and poor return on investment. At the other end of the spectrum products that offer excessive customisation options struggle to meet functional requirements, are difficult to integrate with existing systems and require high overheads for support and maintenance.

QIMR Berghofer has adopted a hybrid approach to this problem through a combination of off the shelf and in-house built software. This talk will describe how this approach has proven successful at the institute, resulting in reduced operational overheads, tighter organisational governance and less administrative burden for academics. With many MRIs and universities expressing strong interest in this software, we welcome this opportunity to introduce you and your institute to the many benefits of accessing this software.

About Michael

After completing degrees in electrical engineering and computer science, Michael began an entrepreneurial career in the tech industry. After ten years founding various startups and running small businesses, Michael took an opportunity at the QIMR Berghofer MRI largely due to a personal interest in the field. Over a period of 8 years he held positions as CIO and then as General Manager of Research Support & Governance. As a current board member of Q-Pharm Pty Ltd, he recently held position as interim CEO for 9 months during the recruitment of a new CEO.

The culmination of this experience has resulted in a new endeavour that will see QIMR Berghofer spin out a new company called Endpoint IQ. This company will focus on commercialising research management software written for the institute as well as developing products and services in the digital health field. The vision for the company is to be seen as a trusted software provider for the medical research industry working in partnership with MRIs across the country.


14

RALPH MITCHELL GERALD EWING Chief Operating Officer Chief Executive Children's Medical Research Institute Children's Medical Research Institute

IAN MUNDY Member Services Director Unimutual

RISKY BUSINESS - INSURING THE UNINSURABLE THROUGH COLLABORATION

Unimutual has a deep and specialised knowledge of the unique challenges faced by universities and research institutions, built from over 25 years of collaboration and expertise in the sector. Owned and operated by its members from the higher education and research sector, Unimutual will take you on a journey from a time where there was no available liability insurance for the sector, to now covering a unique set of risks that cover is unavailable for in the traditional Australian insurance market.

ABOUT RALPH

Ralph Mitchell is the Chief Operating Officer of Children’s Medical Research Institute (CMRI), having commenced with CMRI in 2010 as the Chief Financial Officer. Originally from Sydney, Ralph’s career includes roles in London, New York and Dallas, in private and publicly listed companies, across many commercial sectors. This included a start in public accounting and a period in investment banking, specialising in cross-border takeovers.

ABOUT GERALD

As CEO of Regis Mutual Management in Australia, which manages Unimutual Limited, Gerald has effectively led Unimutual for the past 10 years. During that period, Unimutual has sustained steady growth, and now provides tailored risk protection and management services to its 52 members across the higher education and research sector. Gerald has a track record for sound mutual management, focused on member service underpinned by long term relationships rather than short term profit motives, reflecting the ethos of Unimutual and all mutuals managed by Regis. Gerald’s career spans 40 years in insurance, reinsurance and mutual management, including periods spent in London, Europe and North America. For the last 15 years, his remit has been exclusively mutual, and he has been involved in the start-up and successful management of a number of new mutuals in Australia.

ABOUT IAN

Ian drives Unimutual’s key relationships with brokers, universities, student residential colleges, and research institutes as the Member Services Director. He joined Unimutual in May 2017 with 22 years’ experience in the insurance, general insurance, local government, workers’ compensation and health industries. Ian is passionate about helping the higher education and research sector understand the value of risk protection, and providing specialist risk management advice to Unimutual’s members. Prior to joining Unimutual, Ian held several leading and executive roles in insurance and broking, including JLT, Marsh and Insurance House Group. Ian also launched and ran his own corporate health business for 18 years.

15

AAMRI STRATEGY MEETING WEDNESDAY 6 DECEMBER, 1.30PM – 5.00PM National Ballroom 2, Hotel Realm Canberra Chair: Professor Tony Cunningham AO, AAMRI President AGENDA

1.30pm WELCOME Professor Tony Cunningham AO (Chair), AAMRI President

1.35pm MEDICAL RESEARCH IN AUSTRALIA: A PERSPECTIVE FROM AAHMS

Professor Ian Frazer AC FRS FAA, President, Australian Academy of Health and Medical Sciences (AAHMS)

2.05pm FUTURE PRESCRIPTIONS FOR MEDICAL RESEARCH

Dr Alan Finkel AO, Chief Scientist for Australia 2.35pm A TIME OF CHANGE AT NHMRC

Professor Anne Kelso AO, Chief Executive, National Health and Medical Research Council (NHMRC)

3.15pm AFTERNOON TEA

To be held in National Ballroom 1 3.45pm VicAAMRI: ESTABLISHING A VICTORIAN STATE BRANCH OF AAMRI

Ms Samantha Ludolf, Deputy Director, Strategy and Operations, Walter and Eliza Hall Institute for Medical Research

4.05pm MRIS AND GROWTH IN THE MTP SECTOR

Ms Sue MacLeman, Chief Executive Officer, MTPConnect 4.30pm SHOWING PROGRESS TOWARDS RESEARCH IMPACT: INFORMING

DECISIONS AND PROMOTING INVESTMENT IN RESEARCH Professor Jonathan Carapetis & Dr Tobias Schoep, Telethon Kids Institute

5.00pm CLOSE

AAMRI STRATEGY MEETING

16

PROFESSOR IAN FRAZER AC FRS FAA President Australian Academy of Health and Medical Sciences (AAHMS)

MEDICAL RESEARCH IN AUSTRALIA: A PERSPECTIVE FROM AAHMS

About Ian

Professor Ian Frazer AC is a clinician scientist, trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he leads a research group working at TRI in Brisbane, Australia on the immunobiology of epithelial cancers. He is recognised as co-inventor of the technology enabling the HPV vaccines, currently used worldwide to help prevent cervical cancer. He heads a biotechnology company, Admedus Vaccines, working on new vaccine technologies, and is a board member of several companies and not for profit organisations. He is current president of the Australian Academy of Health and Medical Sciences, and a member of the Commonwealth Science Council. Most recently appointed chair of the Australian Medical Research Advisory Board (AMRAB), the body responsible for developing the strategy and priorities for the Federal Government’s Medical Research Future Fund.

He was recognised as Australian of the Year in 2006. He was recipient of the Prime Ministers Prize for Science, and of the Balzan Prize, in 2008, and was elected Fellow of the Royal Society of London in 2012.

He was appointed Companion of the Order of Australia in the Queen’s Birthday Honours list in 2013.


17

DR ALAN FINKEL AO Chief Scientist for Australia

FUTURE PRESCRIPTIONS FOR MEDICAL RESEARCH

About Alan

Dr Finkel commenced as Australia’s Chief Scientist on 25 January 2016. He is Australia’s eighth Chief Scientist. Prior to becoming Chief Scientist, he was the eighth Chancellor of Monash University and the eighth President of the Australian Academy of Technology and Engineering (ATSE). Since commencing as Chief Scientist, Dr Finkel has led a number of national reviews, including serving as the Chair of the Review into the National Electricity Market (“Finkel Review”) and the 2016 National Research Infrastructure Roadmap. He is leading the STEM Industry Partnership Forum for COAG Education Council, and he serves as the Deputy Chair of Innovation and Science Australia.

Dr Finkel has an extensive science background as an entrepreneur, engineer, neuroscientist and educator. He was awarded his PhD in electrical engineering from Monash University and worked as a postdoctoral research fellow in neuroscience at the Australian National University. In 1983 he founded Axon Instruments, a California-based, ASX-listed company that made precision scientific instruments used at pharmaceutical companies and universities for the discovery of new medicines. After Axon was sold in 2004, Dr Finkel became a director of the acquiring company, NASDAQ-listed Molecular Devices.

In 2006, he focused his career in Australia and undertook a wide range of activities. He led the amalgamation that formed the Florey Neuroscience Institutes; he became Chair of the Australian Centre of Excellence for All-Sky Astrophysics (CAASTRO) and was a director of the ASX-listed diagnostics company Cogstate Limited. He was Executive Chair of the educational software company Stile Education, Chair of Manhattan Investment Group, Chief Technology Officer of Better Place Australia and Chair of Speedpanel Australia.

Dr Finkel was the 2016 Victorian of the Year and the recipient of the Mountbatten Medal (UK). A winner of the Clunies Ross Award for facilitating international neuroscience research, Dr Finkel is committed to science education. He co-founded Cosmos Magazine, which in addition to magazine publishing operates a secondary schools science education program. At ATSE, he led the development and implementation of the STELR program for secondary school science, which has been adopted in more than 600 Australian schools. As Chief Scientist he has led the development of the STARportal information web site for extracurricular STEM activities.

Dr Finkel also established the Australian Course in Advanced Neuroscience to train early career neuroscientists.


18

PROFESSOR ANNE KELSO AO Chief Executive Officer National Health and Medical Research Council (NHMRC)

A TIME OF CHANGE AT NHMRC

About Anne

Professor Anne Kelso AO is the Chief Executive Officer of the National Health and Medical Research Council. Before joining NHMRC in April 2015, Professor Kelso spent many years as a biomedical researcher in immunology at the Walter and Eliza Hall Institute of Medical Research, Queensland Institute of Medical Research and elsewhere. She also served as Director of the Cooperative Research Centre for Vaccine Technology and, most recently, as Director of the World Health Organisation Collaborating Centre for Reference and Research on Influenza at the Doherty Institute. She is a member of several Government and international committees, including the Australian Medical Research Advisory Board (advising the Minister for Health on the strategy and priorities for the Medical Research Future Fund), the Board of the Global Alliance for Chronic Diseases (chair-elect) and the Human Frontier Science Program Organization.


19

MS SAMANTHA LUDOLF Deputy Director, Strategy and Operations Walter and Eliza Hall Institute for Medical Research

VICAAMRI: ESTABLISHING A VICTORIAN STATE BRANCH OF AAMRI

Victoria’s Operational Infrastructure Support (OIS) program was introduced the Brumby government in 2005 to support research costs not covered by a grant or philanthropic sources, such as administration and management functions, commercialisation, facilities and support services. Since that time, the OIS remained static and decreased in real terms due to rising costs (CPI). In 2016, the Victorian independent medical research institutes (iMRIs) formed a group to advocate for the state government to increase OIS.

VicAAMRI, a branch of AAMRI, was established to design a proposition to build on the Victorian Government’s ambition for medical research as a driver of economic and health strategy. Essential activities within the proposition were to educate government representatives on the role of medical research institutes, and their importance in the sector, as well as cementing a partnership between the iMRIs and coordinating a message for all Victorian iMRIs to speak with one voice.

In the 2017/18 budget, the Victorian Government announced an annual uplift of $8 million.

About Samantha

In her role as the Walter and Eliza Hall Institute’s Deputy Director, Strategy and Operations, Samantha Ludolf leads the Professional Services team, encompassing Finance, People and Culture, Information Technology Services, Communications and Marketing, Grants, Bioservices and Laboratory Operations.

Samantha has extensive international and national experience in a range of industries including government, health, justice and business innovation. She has a proven track record of strategy development based on innovative solutions for complex environments and successful implementation and execution.

A highly-connected influencer and excellent communicator, Samantha energises teams and stakeholders to drive change using data to gain insights and measure success. Values-led, Samantha focusses on creating a culture, with structures and processes, that best supports the organisation’s people; setting up robust long-term strategies, financial security and strong diverse leadership to ensure an excellent community research environment.


20

MS SUE MACLEMAN Managing Director and Chief Executive Officer MTPConnect

MRIS AND GROWTH IN THE MTP SECTOR

MTPConnect is an independent, not-for-profit organisation championing a sector-led approach to accelerating the growth of Australia’s medical technology, biotechnology and pharmaceutical (MTP) ecosystem. Established as part of the Australian Government’s Industry Growth Centre Initiative, MTPConnect is working with the sector to drive change, collaboration, and fund big ideas that address sector constrains and gaps on a national scale. MTPConnect Managing Director and CEO Sue MacLeman will provide an overview of the Australian MTP sector, megatrends driving opportunities for development and success in Australia, and outline a number of initiatives supporting growth and commercialisation, such as the recently launched BioMedTech Horizons program.

About Sue

Sue MacLeman is the Managing Director and Chief Executive Officer of MTPConnect, the Australian Government’s Industry Growth Centre for medical technology, biotechnology and pharmaceutical (MTP). Sue has over 25 years’ experience as an executive in the MTP sector, with roles in corporate, medical, commercial and business development at Schering-Plough Corporation (now Merck), Amgen, Bristol-Myers Squibb and Mesoblast Ltd. Sue has also served as CEO and Board member of several ASX and NASDAQ listed companies in the sector and is currently a non-executive director at RHS Ltd., veski and Oventus Medical Ltd. This year Sue was recognised for her leadership in the sector with BioMelbourne Network’s 2017 Women in Leadership Award.


21

PROFESSOR JONATHAN CARAPETIS Executive Director Telethon Kids Institute DR TOBIAS SCHOEP Senior Research Development Officer Telethon Kids Institute

SHOWING PROGRESS TOWARDS RESEARCH IMPACT: INFORMING DECISIONS AND PROMOTING INVESTMENT IN RESEARCH

Interest in measuring research impact emerged in the 1970s when the social responsibilities of scientists were looked at in the context of stringent economic constraints. The Telethon Kids Institute is committed to providing the optimal environment for its researchers to perform translational health and wellbeing research. An important enabler to achieving this objective is effectively bringing stakeholders and partners along with researchers on the journey towards translating research outcomes into positive impacts on child health and wellbeing. To capture and track progress, the Telethon Kids Institute is developing innovative systems for collecting, analysing and visualising a broad range of research impact information in collaboration with sector and industry partners. The design of these systems is being guided by the Telethon Kids Research Impact Framework which is based on a model from the Canadian Academy of Health Sciences and uses tools such as impact indicators, descriptors and case studies to demonstrate how research impacts on health and society. It is anticipated that these systems will also enable researchers to realistically identify barriers to achieving specific research impacts. The research impact systems and tools in development at Telethon Kids are likely to have broader applicability and relevance to other research organisations within the medical research institute, university and government sectors.

About Jonathan

Professor Jonathan Carapetis is the Director of the Telethon Kids Institute in Perth, Western Australia. He is also a Professor at the University of Western Australia and consultant paediatrician at Princess Margaret Hospital. His research interests include Rheumatic fever and rheumatic heart disease, other group A streptococcal diseases, Vaccine-preventable disease, Indigenous child health, Child development and education, Youth health and education and Skin sores and scabies. Jonathan undertook his medical training at the Royal Melbourne and Royal Children’s Hospitals. Previous positions include terms as Theme Director at the Murdoch Children’s Research Institute in Melbourne and Director of the Menzies School of Health Research in Darwin.

About Tobias

Dr Tobias Schoep joined the Research Development team at Telethon Kids Institute with a decade of research experience at the interface of academia and medical biotechnology, working on drug screens, developing recombinant antibodies and bacterial bio-delivery systems. He has worked in


22

both grant funded and venture capital funded environments in Australia and at the University of California at Santa Barbara, contributing as researcher to both grant funding and commercial successes. Tobias provides operational and project management support to a number of key Research Development initiatives. He provides strategic and informed advice on how researchers’ outputs give insight into the progress of Telethon Kids along pathways towards improved child health, development and wellbeing. He enables evidence based approaches to managing research in the context intended impacts, and is developing innovative new tools for informing engagement with funders, donors and other stakeholders.

Association of Australian Medical Research Institutes

ABN 12 144 783 728

PO Box 2097 Royal Melbourne Hospital VIC 3050

[email protected] 03 9345 2500

www.aamri.org.au @AAMRI_Aus

Documents

6&7 December Hotel Realm - aamri.org.au · PDF fileMiss Samantha Ludolf Deputy Director, Strategy & Operations Walter and Eliza Hall Institute of Medical Research